HCM vs HLN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCM is a StrongBuy and HLN is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HCM’s FA Score shows that 2 FA rating(s) are green whileHLN’s FA Score has 1 green FA rating(s).
- HCM’s FA Score: 2 green, 3 red.
- HLN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCM’s TA Score shows that 5 TA indicator(s) are bullish while HLN’s TA Score has 5 bullish TA indicator(s).
- HCM’s TA Score: 5 bullish, 5 bearish.
- HLN’s TA Score: 5 bullish, 5 bearish.
Price Growth
HCM (@Pharmaceuticals: Other) experienced а +22.65% price change this week, while HLN (@Pharmaceuticals: Other) price change was +9.06% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.48%. For the same industry, the average monthly price growth was -4.83%, and the average quarterly price growth was -11.76%.
Reported Earning Dates
HCM is expected to report earnings on May 28, 2025.
HLN is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+2.48% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| HCM | HLN | HCM / HLN | |
| Capitalization | 2.88B | 38.4B | 8% |
| EBITDA | 67.3M | 2.35B | 3% |
| Gain YTD | 3.331 | 5.975 | 56% |
| P/E Ratio | 27.95 | 29.23 | 96% |
| Revenue | 838M | 11.3B | 7% |
| Total Cash | 886M | 994M | 89% |
| Total Debt | 86.1M | 9.46B | 1% |
HCM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 67 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 33 | |
PRICE GROWTH RATING 1..100 | 79 | |
P/E GROWTH RATING 1..100 | 5 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| HCM | HLN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 64% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 65% |
| Momentum ODDS (%) | 1 day ago 81% | 1 day ago 54% |
| MACD ODDS (%) | 1 day ago 81% | 1 day ago 48% |
| TrendWeek ODDS (%) | 1 day ago 74% | 1 day ago 52% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 36% |
| Advances ODDS (%) | 1 day ago 76% | 1 day ago 57% |
| Declines ODDS (%) | 8 days ago 81% | 14 days ago 47% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 31% |
HCM and
Correlation & Price change
A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.
| Ticker / NAME | Correlation To HCM | 1D Price Change % | ||
|---|---|---|---|---|
| HCM | 100% | +8.53% | ||
| ACET - HCM | 29% Poorly correlated | +5.40% | ||
| SNDL - HCM | 25% Poorly correlated | -2.21% | ||
| IRWD - HCM | 24% Poorly correlated | -31.48% | ||
| CPHI - HCM | 24% Poorly correlated | -0.85% | ||
| HLN - HCM | 23% Poorly correlated | +0.50% | ||
More | ||||
HLN and
Correlation & Price change
A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.
| Ticker / NAME | Correlation To HLN | 1D Price Change % | ||
|---|---|---|---|---|
| HLN | 100% | +0.50% | ||
| HLNCF - HLN | 49% Loosely correlated | +1.01% | ||
| TAK - HLN | 30% Poorly correlated | +3.03% | ||
| ZTS - HLN | 29% Poorly correlated | +0.93% | ||
| BHC - HLN | 25% Poorly correlated | +0.46% | ||
| VTRS - HLN | 25% Poorly correlated | +1.19% | ||
More | ||||